2026 Medical Imaging Industry Booms: Policy Support, AI Integration and Commercial Diversification Drive Sustainable Development
2026-04-15
April 15, 2026 – The global Medical Imaging industry is experiencing unprecedented growth in 2026, driven by the joint promotion of national policy regulation optimization, artificial intelligence (AI) technology integration, and diversified commercial model innovation. Medical Imaging, as a core pillar of modern medical diagnosis and treatment, has broken through the bottlenecks of traditional development and moved towards a new stage of intelligent, standardized and inclusive development, bringing substantial changes to global medical and health services and benefiting hundreds of millions of patients around the world.
In March 2026, the new national medical service price policy officially implemented in China has become a key driving force for the healthy development of the Medical Imaging industry. The new policy, jointly issued by the National Medical Security Administration and the National Health Commission, clearly stipulates the unified price limit, price transparency and national mutual recognition of results for large-scale Medical Imaging examinations such as CT and MRI, which has effectively standardized the market order of Medical Imaging and reduced the economic burden of patients seeking Medical Imaging services.
According to the latest data released by the National Medical Security Administration, after the implementation of the new policy, the average price of single-part CT plain scan in tertiary hospitals has dropped to no more than 280 yuan, a decrease of 20% to 35% compared with the previous period, while the average price of 1.5T MRI plain scan has been reduced to no more than 480 yuan, with an average decrease of 25% to 40%. The new policy also cancels forced film fees, split charges and cross-institution retrieval fees for Medical Imaging, making Medical Imaging services more affordable and accessible to the public.
Medical Imaging has always been an important application field of AI technology, and in 2026, the integration of AI and Medical Imaging has achieved remarkable breakthroughs, further releasing the value of Medical Imaging in clinical diagnosis. AI Medical Imaging technology uses advanced algorithms such as convolutional neural networks and Vision Transformer to automatically extract features from Medical Imaging images, realize rapid identification and classification of lesions, and effectively make up for the shortages of traditional manual interpretation such as heavy workload, long diagnosis time and unavoidable misdiagnosis.
Relevant clinical data show that AI-assisted Medical Imaging interpretation can save 53% of the time compared with manual interpretation, increase the detection rate by 17.6%, and the recall rate and biopsy positive predictive value are 18.3% and 9.3% higher than those of the manual group respectively. Many leading enterprises have launched mature AI Medical Imaging solutions, such as United Imaging Healthcare’s “Yuanzhi” large model, which supports more than 10 imaging modalities and over 300 Medical Imaging processing tasks, with an accuracy rate of over 95% in key clinical tasks such as complex lesion diagnosis and organ segmentation.
The commercialization of Medical Imaging is also showing a diversified development trend in 2026, and the business model of Medical Imaging is constantly iterating and optimizing to adapt to the needs of different types of medical institutions. At present, the commercialization paths of Medical Imaging mainly include four types: software license sales model, SaaS model, software and hardware integration binding model, and platform profit sharing and third-party diagnosis service model.
The software license sales model is one of the most mainstream landing methods of Medical Imaging products, which is suitable for large and medium-sized medical institutions with strong capital strength and stable demand. Medical Imaging enterprises sell AI Medical Imaging software products that have obtained NMPA medical device registration to hospitals and third-party Medical Imaging centers through one-time authorization, and provide basic upgrade services for a long time. The SaaS model, with cloud deployment as the core, charges continuous service fees according to the usage of medical institutions, which greatly reduces the initial investment cost of medical institutions and is especially suitable for primary hospitals and small and medium-sized medical institutions.
The software and hardware integration binding model is mainly led by Medical Imaging equipment manufacturers. Medical Imaging equipment manufacturers embed AI functions into CT, MR, ultrasound, DR and other Medical Imaging equipment by independently developing AI software or cooperating with professional AI enterprises to realize the package sales of “hardware equipment + AI software”, and charge AI software fees according to a certain proportion of the equipment price. The platform profit sharing and third-party diagnosis service model focuses on the primary medical market, helping Medical Imaging enterprises quickly expand the sinking market and realize large-scale monetization.
In addition to policy and technology drivers, the continuous expansion of market demand has also provided a broad space for the development of the Medical Imaging industry. With the aging of the global population and the increasing incidence of chronic diseases such as cardiovascular and cerebrovascular diseases and tumors, the demand for Medical Imaging examinations such as early screening, diagnosis and follow-up of diseases is growing day by day. Medical Imaging, as an important means of early detection of lesions, can find potential lesions in the early stage of diseases when patients may not have obvious symptoms, providing a valuable time window for early treatment of patients and greatly improving the cure rate and survival rate.
Taking lung cancer screening as an example, low-dose CT Medical Imaging can effectively find early lung cancer nodules, and the early diagnosis rate of lung cancer can be increased by more than 50% through timely Medical Imaging screening. For patients with cardiovascular and cerebrovascular diseases, Medical Imaging such as cerebral vascular CTA and cardiac ultrasound can help doctors accurately identify vascular stenosis, plaques and other abnormalities, providing an important basis for the formulation of treatment plans. Medical Imaging also plays an irreplaceable role in the diagnosis of orthopedic fractures, neurological diseases and gynecological diseases.
The continuous improvement of the approval system of Medical Imaging products has also laid a solid foundation for the healthy development of the Medical Imaging industry. As of June 2025, China has approved 122 AI Medical Imaging auxiliary diagnosis software NMPA registration certificates, including 8 Class II certificates and 114 Class III certificates. The product matrix of Medical Imaging has covered multiple fields such as cardiovascular diseases, lung diseases, cerebrovascular diseases and orthopedic examinations, providing rich choices for medical institutions and patients.
In the global market, the scale of the Medical Imaging industry is also growing steadily. According to the data released by Frost & Sullivan, the global AI Medical Imaging market size is expected to reach 97.6 billion yuan by 2028, with a compound annual growth rate of 55.6% from 2023 to 2028. Among them, the proportion of the Medical Imaging field in the overall AI medical market has exceeded 40% in 2024, becoming the core growth pole of the AI medical industry.
Medical Imaging centers, as an important carrier of Medical Imaging services, are also accelerating the pace of intelligent transformation. Medical Imaging centers rely on standardized inspection processes to produce a large number of high-quality and standardized Medical Imaging data, which provide sufficient data support for the research and development and iteration of AI Medical Imaging algorithms. At the same time, AI technology empowers Medical Imaging centers in the whole process of equipment optimization, auxiliary diagnosis, auxiliary treatment and data quality control, effectively reducing operating costs and improving service efficiency and diagnosis accuracy.
Taking the “Yueyi Zhiying” AI-assisted Medical Imaging interpretation system launched in Guangdong Province as an example, the system covers intelligent analysis of 7 common Medical Imaging examinations such as CT lung nodule auxiliary diagnosis, and has been freely provided to nearly 5,000 medical institutions in the province. Relying on advanced AI models, Medical Imaging can automatically identify various common diseases and generate structured reports, realizing second-level results and improving the diagnosis accuracy to 98%, which has greatly improved the level of Medical Imaging diagnosis and service efficiency of medical institutions.
Despite the rapid development of the Medical Imaging industry, Medical Imaging still faces some challenges in the process of development, such as data privacy and compliance issues, insufficient model interpretability, and high cost of data annotation. However, with the continuous improvement of relevant policies, the continuous breakthrough of technology and the continuous optimization of commercial models, these challenges will be gradually solved, and the Medical Imaging industry will usher in a more brilliant development prospect.
Industry insiders said that in the future, Medical Imaging will further deepen the integration with AI, big data, 5G and other technologies, promote the development of Medical Imaging towards precision, intelligence and informatization, and further expand the application scenarios of Medical Imaging. Medical Imaging will not only play a more important role in clinical diagnosis and treatment, but also promote the reform of the medical and health system, help achieve the goal of “preventing and treating diseases before they occur”, and bring more benefits to global patients.
In the context of global medical and health upgrading, Medical Imaging, as a key link connecting medical diagnosis and treatment, will continue to play a core role in promoting the high-quality development of the medical industry. With the joint efforts of governments, enterprises, medical institutions and other parties, the Medical Imaging industry will surely enter a new era of sustainable development, making greater contributions to improving global medical and health services and protecting people’s health.